Anorexia Nervosa and Its Effects on Brain Function, Body Metabolism and Their Interaction
AVAIN-PET
Anorexia Nervosa and it's Effects on Brain Function, Body Metabolism and Their Interaction
1 other identifier
observational
25
1 country
1
Brief Summary
The neuromolecular and metabolic underpinnings of Anorexia Nervosa (AN) are studied using multi-modal molecular (positron emission tomography with two different radioligands) and functional (functional magnetic resonance imaging) neuroimaging in a prospective design. Subjects with AN and normal weight adolescents will be studied with PET and MRI and followed for five years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 12, 2021
CompletedFirst Posted
Study publicly available on registry
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedDecember 17, 2024
December 1, 2024
4 years
October 12, 2021
December 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in brain reward system and metabolism in AN patients
AN patients and controls are studied using fMRI and PET imaging and followed 10 years. Reward system function is measured using functional MRI and metabolism using 18F-fluorodeoxy glucose and PETCT imaging
10 years
Predictive value of baseline body mass index (BMI), functional brain activation and metabolism in AN
Results from baseline are combined with follow updata
10 y
Study Arms (1)
patients and controls
AN patients and controls are recruited, studied using imaging and followed for 5 years
Eligibility Criteria
Totallly 30 female subjects with anorexia nervosa are recuited from the Eating Disorder Unit at the Turku University Hospital who meet the following criteria: i) modified DSM-IV diagnosis of AN with or without amenorrhea; ii) AN onset before the age of 25 years; iii) age between 18 and 32 3 years; iv) no lifetime history of binge eating. Their data are compared with 30 age and sex-matched healthy controls
You may qualify if:
- Female sex
- Age 18-32 3 years
- BMI \< 17.5 kg/m2
- Currently fulfilling modified DSM-IV diagnosis of AN with or without amenorrhea, onset age before 25 years
- Diagnosed less than 2 years ago
- For controls:
- Female sex
- Age 18-32 3 years
- BMI 19 20-25 kg/m2
- No lifetime history of obesity (BMI ≥\> 30) or eating disorders
You may not qualify if:
- Any chronic disease or medication that could affect glucose metabolism or neurotransmission
- History of psychiatric disorders (excl. AN for the corresponding study group)
- Smoking of tobacco, taking of snuffs, or use of narcotics
- Abusive use of alcohol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Turku PET Centre
Turku, 20521, Finland
Biospecimen
Blood sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pirjo Nuutila, MD, PhD
Turku PET Centre, Turku University hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 12, 2021
First Posted
November 1, 2021
Study Start
November 1, 2020
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
December 17, 2024
Record last verified: 2024-12